Lv31
280 积分 2023-02-28 加入
Epigenetics of myelodysplastic syndromes
1小时前
已完结
Subcutaneous daratumumab plus pomalidomide and dexamethasone versus pomalidomide and dexamethasone in patients with relapsed or refractory multiple myeloma (APOLLO): extended follow up of an open-label, randomised, multicentre, phase 3 trial
16天前
已完结
Teclistamab plus Daratumumab in Relapsed or Refractory Multiple Myeloma
22天前
已完结
First-in-human study of AMG 193, an MTA-cooperative PRMT5 inhibitor, in patients with MTAP-deleted solid tumors: results from phase 1 dose exploration
1个月前
已完结
Health-related quality of life of newly diagnosed chronic myeloid leukemia patients treated with first-line dasatinib versus imatinib therapy
2个月前
已完结
MTAP is an independent prognosis marker and the concordant loss of MTAP and p16 expression predicts short survival in non-small cell lung cancer patients
3个月前
已完结
New promises and challenges in the treatment of advanced non-small-cell lung cancer
4个月前
已完结
PRMT5: A Promising Synthetical Lethal Target for MTAP-Deleted Cancers
4个月前
已完结
Alterations within the Osteo-Hematopoietic Niche in MDS and their Therapeutic Implications
5个月前
已关闭
Myelodysplastic Syndromes
5个月前
已完结
皖公网安备34019202002308
